Figures
Abstract
Furnas do Dionísio is a Brazilian Afro-descendant settlement in the city of Jaraguari, 21.4 miles from Campo Grande, Mato Grosso do Sul, Brazil. Approximately 96 families live in this quilombola (Maroon) settlement, also known in Brazil as a remnant community of descendants of African slaves. Recent studies found 20% of households were infested by triatomines, 18% of insects captured in the community were infected by Trypanosoma cruzi, and 22.7% of dogs presented T. cruzi antibodies. The low prevalence of Chagas disease observed in humans in Mato Grosso do Sul State is attributed to its arrival via colonist migration and subsequent transplacental transmission. In order to gain a better understanding of the T. cruzi cycle in residents of the study community, serological and molecular tests were carried out to diagnose Chagas disease. In the present study, 175 residents between 2 and 80 years old were included. A total of 175 participants were interviewed and 170 provided blood samples, which were tested for T. cruzi antibodies with serological tests. Molecular diagnosis was performed in 167 participants by PCR (KDNA) and NPCR (satellite DNA) tests. One of the 170 samples tested positive for all serological tests performed. The overall frequency of Chagas disease in the community was low (0.6%). Interview responses revealed that 66.3% knew of triatomine insects and 65.7% reported having had no contact with them. Physical improvements to residences, together with vector surveillance and control by the State and municipal governments and local ecological conservation contribute to the low frequency of the Chagas disease in this quilombola community.
Citation: Martins MFdS, Pereira MB, Ferreira JdJG, França AdO, Cominetti MC, Ferreira EdC, et al. (2018) Serological and molecular inquiry of Chagas disease in an Afro-descendant settlement in Mato Grosso do Sul State, Brazil. PLoS ONE 13(1): e0189448. https://doi.org/10.1371/journal.pone.0189448
Editor: Alain Debrabant, US Food and Drug Administration, UNITED STATES
Received: April 6, 2017; Accepted: November 24, 2017; Published: January 9, 2018
Copyright: © 2018 Martins et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: There are ethical and legal restrictions to sharing our underlying data set publicly. The study is based on the interviews and analysis of biological material such as blood, serum and DNA from a rural population, descendants of slaves. These restrictions have been imposed by the National Health Council, Brazilian Federal Constitution, and the CONEP (National Council of Ethics in Research) which guarantees the confidentiality of information when conducting research involving human subjects. Data requests may be sent to the Fiocruz Mato Grosso do Sul, located at Rua Gabriel Abrão, 96, Jardim das Nações, CEP 79081-746, Campo Grande, Mato Grosso do Sul State, Brazil. Phone: (+55 67) 3346 4693 or (+55 67) 3346 4480.
Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was supported by the FUNDECT - Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul, edital number 04/2013, Programa de Pesquisa para o Sistema Único de Saúde, Mato Grosso do Sul, PPSUS, Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq, Ministério da Saúde,MS. Process: 0056/13, URL: http://fundect.ledes.net/.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Furnas do Dionísio is a community predominantly comprised of descendants of African slaves (quilombolas or Maroons) in the city of Jaraguari, located 21.4 miles from Campo Grande, the capital of Mato Grosso do Sul State, Brazil. This community remained isolated until several decades ago due to difficult access and cultural differences. However, the community’s social customs and values were preserved. There are approximately 96 households in the settlement and more than 90% of residents are Afro-descendants. The main chronic diseases in Furnas do Dionísio are sickle cell anemia and hypertension. In 1997, the National Health Foundation (FUNASA) started a project to build or rebuild homes in the community to eradicate Chagas disease and improve the quality of life of residents [1]. Significant improvements in sanitary, educational, and social conditions occurred between 2010 and 2013. Only quilombola communities recognized by the federal government, of which there are 2,197 [2], participate in these actions.
Chagas disease in Brazil [3] and in Mato Grosso do Sul State receive insufficient research attention. Triatoma infestans, the main transmitting insect of Chagas disease is not common in the Brazilian cerrado and Pantanal. Certification of interruption of transmission by Triatoma infestans occurred in 2006. However, Triatoma sordida is a widespread species in Mato Grosso do Sul habitats, is frequent in peridomicile environments, and has the capacity to establish itself in house interiors, especially in homes presenting precarious living conditions and physical characteristics [4].
T. sordida is native to the Brazilian cerrado, mainly located in the Central-West region, and has the capacity to establish itself inside houses when natural habitats are destroyed, or food sources are scarce [5, 6].
Research carried out in Mato Grosso do Sul State showed intense presence of T. sordida around and inside houses. The occurrence of Trypanosoma cruzi in this predominant insect species was 0.5% inside households [4]. In Furnas do Dionísio, Cominetti and collaborators [7] found 20% of houses were infested by triatomines. Parasitological and molecular techniques demonstrated the presence of T. cruzi in 18% of captured insects.
In Furnas do Dionísio, immunological tests demonstrated the presence of T. cruzi antibodies in 22.7% of dogs, corroborating the understanding that dogs are reservoirs for T. cruzi and play an important role in its domestic and wild cycles. This study was important for determining the presence of trypanosomatids in this community and the risk to humans of contracting the disease [8]. Locally contracted human cases of Chagas disease have also been reported in Mato Grosso do Sul State [9, 10].
Trypanosoma cruzi and Leishmania spp. belong to order the Kinetoplastida and family Trypanosomatidade. Serological tests for Chagas disease may show cross reaction with Leishmaniasis. In Mato Grosso do Sul State, leishmaniasis is endemic and considered a significant public health problem, with 42.9 cases of visceral leishmaniasis and 21.6 of cutaneous leishmaniasis per 100,000 inhabitants being reported from 2010 to 2013 [11].
Investigations in Mato Grosso do Sul State demonstrated low prevalence of Chagas disease cases (0.9%), which is related to the state’s history of colonization, mainly through migration from the South and Southeast regions, where Chagas disease is endemic. Local infections may occur through transplacental transmission [9, 10]. Therefore, studies of the presence of T. cruzi are needed to establish the epidemiological profile of Chagas disease in Mato Grosso do Sul State.
The aim of this study is to determine the frequency of Chagas disease and evaluate possible associations with epidemiological and social factors in a rural population of quilombolas in Mato Grosso do Sul.
Material and methods
Furnas do Dionísio is an Afro-descendant settlement located in the city of Jaraguari, 21.4 miles from Campo Grande, the capital of Mato Grosso do Sul State. The community occupies approximately 1,031 ha, with its center at the coordinates 20°9′1.34″S and 54°34′27.17″W. The community is comprised of small rural properties with masonry houses [7].
Ethics committee
The present study was approved by the Ethics Committee of the Federal University of Mato Grosso do Sul under the CAAE number: 16382413.6.0000.0021. Individuals over 18 years signed the consent form and responded to the social and epidemiological questionnaire. Parents of children and youth under 18 years provided written consent for collection of blood and interview data.
Socio-epidemiological interview and sample collection
A total of 175 patients were screened for Chagas disease from July to December 2014 (S1 Table). The social and epidemiological questionnaire included questions regarding personal information, such age, sex, and educational level, and epidemiological data, such as contact with triatomines, knowledge of Chagas disease, and clinical signs such as fatigue, dysphagia, and/or difficulty with evacuation. Interviews were conducted and blood samples collected by members of the research team during the same opportunity (S1 Questionnaire). For children under six, a parent or legal guardian provided responses. An anonymous identification number was used to identify information in questionnaires. A total of 175 blood samples were collected for molecular and serological tests.
Serological tests
One hundred and seventy participants were evaluated with serological tests. T. cruzi IgG antibodies were measured by indirect immunofluorescence (IIF), chemiluminescent microparticle immunoassay (CMIA), and enzyme-linked immunosorbent assay (ELISA). IIF tests were performed using T. cruzi epimatigotes as antigen (Imunocruzi®, Biolab-Mérieux, Rio de Janeiro, Brazil) and an anti-human IgG fluorescein conjugate (Fluoline G®, bioMérieux, Lyon, France). IIF titers ≥ 1:40 were considered reactive (R) for T. cruzi antibodies. CMIA tests were performed on fully automated equipment (Abbott Architect i2000SR) using the Architect Chagas Assay (Abbott Laboratories, Germany), according to the manufacturer's instructions. Assay results are presented as a ratio of the specimen signal in relative light units (RLUs) to the cutoff value (S/CO), where S/CO values < 0.8 are considered nonreactive (NR) for T. cruzi antibodies, S/CO values ≥ 1.00 are considered reactive (R) for T. cruzi antibodies, and S/CO values from ≥ 0.80 to < 1.00 are considered grayzone (GZ). All samples were tested by ELISA (Dia Pro Diagnostic Bioprobes T. cruzi–Ab), following the manufacturer’s instructions and standard laboratory protocols.
Molecular tests
DNA isolation.
DNA from whole blood samples was extracted in 175 samples, using the Wizard® Genomic DNA purification kit Promega, following the manufacturer's instructions. DNA quality and absence of inhibitors were tested with amplification of the human β- globin gene using Go Taq® Green Master Mix, 1 μl of DNA in a final volume for 20 μL. PCR for β-globin using PCO3: 5′ ACACAACTGTGTTCACTAGC 3′ and PCO4: 5′ CAACTTCATCCACGTTCACC 3′ primers under the following PCR conditions: initial denaturation at 95°C for 15 min, 35 cycles with the cycling profile of 95°C for 1 min, 52°C for 1 min, 72°C for 1 min, and final extension for 5 min at 72°C.
PCR and NPCR.
Detection of T. cruzi parasites kDNA (kinetoplast DNA) PCR was performed using the primers kDNA, S35: 5’AAATAATG (T/G) ACGGGTGAGATG CA 3’ and S36: 5’ GGGTTCGATTGGGGTTGGTGT 3’ generating a fragment of 330bp [12]. The PCR reaction was prepared to a final volume of 20 μL using 1 μL of DNA template, 50 mM of potassium chloride, 10 mM of Tris-HCl (pH 8.4), 2.0 mM MgCl2, 2.0 mM dNTP mix (Ludwig Biotec), 5.0 units of Platinum Taq polymerase (Invitrogen) and 10 pmol of each primer. Amplification of template DNA was processed in an automatic thermocycler (MJ Research PTC 200 Thermal Cycler) with initial denaturation at 94°C for 5 min, alternating 30 cycles of denaturation at 94°C for 1 min, annealing at 65°C for 1 min and extension at 72°C for 1min, followed by a step of final extension at 72°C for 10 min.
Another target for amplification by Nested-PCR (NPCR), directed to satellite DNA, was performed utilizing the primers TCZ1: 5’ CCGAGCTCTTGCCCACACGGGTGCT 3’; 5’ TCZ2: CCTCCAAGCAGCGGATAGTTCAGG3’ for first reaction and TCZ3: 5’ TGCTGCA(G/C)TCGGCTGATCGTTTTCGA 3’; TCZ4: 5’ CA(A/G)G(C/G)TTGTTTGGTGTCCAGTGTTGTGA 3’ for second reaction, [13, 14]. The first reaction was performed with 1 μL of the DNA sample, 50 mM of potassium chloride, 10 mM of Tris-HCl (pH 8.4), 1.8 mM magnesium chloride, 10 pmol of each oligonucleotide (TCZ1/TCZ2), 1.5 mM dNTP mix (Ludwig Biotec) and 5.0 U of Platinum Taq DNA polymerase (Invitrogen) for a final volume of 20 μL. The second reaction was performed with TCZ3 and TCZ4 primers following the same protocol. For the second reaction, the MgCl2 concentration was modified to 2.0 mM and a sample of the PCR product (0.5–1.0 μL) was re-amplified with the TCZ3 and TCZ4 oligonucleotides, which resulted in a fragment of 149 bp for positive samples [14].
The temperature profile for denaturation was 95°C for 5 min. The reaction mixtures were subjected to 5 cycles of amplification in a programmable thermal cycler. During each cycle, the samples were incubated at 95°C for 30 s, 60°C for 30 s and 72°C for 1 min. In the next 25 cycles, the anneal temperature of primers was altered to 65°C. At the end of the last cycle, samples were incubated at 72°C for 10 min. Approximately 0.7 μL of the reaction was used for the second amplification, where primers TCZ3 and TCZ4 amplified a 149 nucleotide internal sequence of the same repetitive sequence. In the NPCR, the cycles were differentiated: 94°C for 5 min (one cycle); 94°C for 40 s; 55°C for 40 s; 72°C for 1 min and 30 s (25 cycles); and a final extension for seven minutes (72°C). The amplified fragment of 149 bp was separated by electrophoresis on a 2% agarose gel stained with ethidium bromide and visualized by ultraviolet transilluminator.
Positive controls for PCR assays were isolated a patient with clinical compatibility, positive serology, and positive epidemiology for Chagas disease. Blood samples were multiplied by blood culture and genotyped as DTU II. As a negative control, DNA of individuals with clinical, serological, and epidemiology negatives for Chagas disease were included. To check the quality of reagents, all reagents without DNA in each reaction were subjected to amplification cycles.
Results
Questionnaire data were tabulated and simple percentages were calculated for each item. A total of 175 participants and/or parents or guardians agreed to be interviewed (Table 1). Of the 16 children (9.1%) under six years old who participated in the study, complete information was collected for 5 (31.3%). Of the 39 (22.3%) participants in the age group 7 to 14 years, incomplete information was registered for 12 (30.7%). Of the 175 participants, interview data for 23 (13.1%) children aged 2 to 14 years old were incomplete or absent. The data in Table 1 shows the age groups of interviewees (2–6 and 7–14 years). Table 2 shows responses to questions regarding epidemiological and social conditions. The proportions of missing data due to lack of response varied between questions from 10.8% to 14.8%, due to incomplete or absent answers in the age group 2 to 14 years.
A total of 175 participants provided biological samples. Of these, 79 (45.1%) were female and 96 (54.9%) were male. Additionally, 58 (33.1%) were from 40 to 59 years of age and 177 (66.9%) had no more than primary education (Table 1). Socio-epidemiological characteristics, including contact with triatomines, knowledge of Chagas disease, and clinical signs, are presented in Table 2. Of 175 participants, 127 (72.6%) did not have relatives with Chagas disease. Whereas 116 (66.3%) reported having knowledge the insect, 115 (65.7%) indicated having had no physical contact with it.
Serological tests were performed in 170 of the 175 samples collected, due to lack of serum in five samples. The prevalence of Chagas disease was 0.6% (01/170). Of the 170 serum samples tested with ELISA, CMIA, and IIF, only one sample (FD 75) was positive. This sample presented values for ELISA and CMIA ≥ 1.00. The IIF titers ≥ 1:40 were considered reactive (R) for T. cruzi antibodies. This sample (FD75) was from a 25 years old woman who was born and lived in the quilombola community.
Of the 175 samples subjected DNA extraction and subjected to the PCR test for the human β-globin gene, 167 presented DNA with adequate quality for detection of T. cruzi with PCR. These were therefore tested for the two targets KDNA (Fig 1) and satellite DNA (Fig 2). Only participant FD75 presented positive, consistent with the serological test results.
M: Ladder 100 bp, Invitrogen ®; C+: T. cruzi DTU II; C-: DNA of patients who tested negative for Chagas disease; 75: PCR positive for T. cruzi KDNA; 74, 76–78: PCR negative for T. cruzi KDNA; W: PCR without DNA.
M: Ladder 100 bp, Invitrogen ®; C+: T. cruzi DTU II; C-: DNA of patients with negative serologies and epidemiologies for Chagas disease; 75: NPCR positive for T. cruzi satellite DNA; 76–78: PCR negative for T. cruzi satellite DNA; W: NPCR without DNA.
Discussion
In the present study, the low prevalence (0.6%) of Chagas disease in an Afro-descendant settlement in Mato Grosso do Sul State was detected by molecular (PCR) and serological (IIF, ELISA, and CMIA) tests. This finding is attributable to the ecology of the primary transmitting insect (T. infestans), which is uncommon in the Brazilian cerrado and Pantanal and is considered controlled in Brazil [15, 16].
T. sordida is the most important vector species for T. cruzi in the Central-West region and is most abundant in peridomicile habitats [4]. The vector capacity of T. sordida is limited because it is mainly ornithophilic. Low rates of T. cruzi are observed in birds because they are refractory to infection. The insect is commonly established in the peridomicile and may be part of wild and domestic cycles, but has a weak tendency to invade or colonize households [16, 17, 18, 19].
Domestic mammals are considered sentinels because their infection by T. cruzi precedes human infection [20]. Chagas disease has been observed in dogs in this community [21], although the present study did not find an expressive frequency of T. cruzi infection in the human population.
Another important factor in the observed low prevalence of Chagas disease is that the study community has undergone major housing changes since 1997, including the construction or reconstruction of masonry houses by a National Health Foundation (FUNASA) project aimed to eradicate Chagas disease [1]. This intervention reduced the infestation of triatomines inside the houses and, consequently, impeded the transmission of the disease in the population.
According to the II Brazilian Consensus on Chagas Disease (II Consenso Brasileiro em Doença de Chagas) [22], laboratorial diagnosis should be performed by two serological tests based on different principles. Hemagglutination, IIF, and ELISA are the most commonly used tests. Despite advances, these serological tests can result in cross-reactions, especially where leishmaniasis is endemic. Parasitological tests such as xenodiagnosis and blood culture are quite specific, but have low sensitivity in cases of chronic Chagas disease with small numbers of circulating parasites. DNA amplification by PCR is a sensitive and specific test to detect T. cruzi DNA in blood samples obtained from chronic chagasic patients, and therefore is a promising tool to complement conventional serological tests [23].
Diagnosis by PCR should not be used as a routine test because there is no standard protocol [22, 24]. However, despite differences in sensitivity and specificity requirements between protocols [24], PCR is used as a complementary test for Chagas disease diagnosis, especially in patients with doubtful [23] or negative serology but with clinical and epidemiological signs validating obtained results [25].
In the present study, three immunological tests (IIF, CMIA, and ELISA) and two PCR targets (kDNA and nuclear DNA) had the same result, confirming the high sensitivity of serological tests and high specificity of PCR. During the chronic phase of Chagas disease, the sensitivity of ELISA and CMIA tests is 100%, while IIF reaches 93%. The specificity of these immunological tests is 98.7% to 100% for ELISA, 99% for IIF, and 97.5% for CMIA [26, 27]. Due to the lack of accuracy of commercially available serological tests, a review by Coura and colleagues [28] reinforces that two serological tests are necessary for laboratory diagnosis of chronic Chagas disease, as currently indicated by the II Brazilian Consensus on Chagas Disease [22].
Studies in Mato Grosso do Sul demonstrate that Chagas disease prevalence in humans is low (between 0.05% and 3%) and local infections are present [9, 10, 28, 29, 30, 31]. In this study, the results confirm the low prevalence (0.6%) of Chagas disease in the rural community of Furnas do Dionísio in Mato Grosso do Sul State, as previously reported in the literature.
Interview data were incomplete or absent for 23 children (13.1%) between 2 and 14 years old, representing a potential study limitation with regard to questions addressing knowledge of Chagas disease (Table 2). Because the quilombola settlement is located about 21.4 miles from Campo Grande, approximately half of residents (55.4%) were born in this city. Most of the adult population had some primary education and the community now has a school offering primary and secondary education, which is attended by most children and youth. The majority of participants (72.6%) reported having no family history of Chagas disease and 49.7% had no previous knowledge of it (Table 2). Yet, 66.3% reported having knowledge of the insect, which they encounter in corrals, pigsties, chicken coops, and barns (data not shown). These triatomines may or may not be relevant vectors of Chagas disease in this community. Because the local environment is rural and close to natural vegetation, other genera in the Triatominae family may also be present.
Positive aspects of the study included seeking to evaluate the entire population, which represented a wide range of ages, from 2 to 83 years and with a mean age of 31.7 ± 21 years. These findings suggest there is no vector transmission in this community despite evidence that T. cruzi is present in domestic and synanthropic animals [7] and in triatomines [32]. Furthermore, the results suggest that the parasite cycle occurs in the wild, mainly in the preserved natural areas near the community. This is the first published study of Chagas disease prevalence in a quilombola community in Mato Grosso do Sul, Brazil. In a rural area of Mexico, a similar study demonstrated a low seroprevalence of 4.8%, even though triatomines were abundant in the region [33]. Similar to the present study, this research in Mexico reinforces that vector surveillance with health education programmes in communities should be strengthened.
The Chagas disease is considered emergent in Texas (USA) and Europe. There is growing concern within the scientific community about the emergence and reemergence of neglected diseases [34, 35]. According to the II Brazilian Consensus on Chagas Disease [22], which estimated the overall prevalence in Brazil to be between 1% and 2.4%, more studies and inquiries should be carried out that integrate the production of knowledge of the disease between such diverse fields as epidemiology and transmission dynamics. This study in the Afro-descendant settlement Furnas do Dionísio revealed a prevalence of 0.6%, corroborating previous findings in the same community [7, 32]. Vector transmission was low and the Trypanosoma cruzi cycle occurs in natural habitats.
The low prevalence of Chagas disease in the Furnas do Dionísio quilombola community suggests that the T. Cruzi cycle is present and occurs between synanthrope, wild, and domestic animals. Human involvement is unlikely. While carrying out the present study, it was evident that a number of the residents customs, such as cultivating foods, raising animals, respecting the land, and concerning themselves with conserving natural vegetation around their properties, resulted in respect for the environment and sustainable production. Care for the environment observed in the community is important for controlling anthropozoonoses and other disorders that may results from lack of environmental protection.
Supporting information
S1 Questionnaire. Social and epidemiological questionnaire for Chagas disease.
https://doi.org/10.1371/journal.pone.0189448.s002
(DOCX)
Acknowledgments
We would like to thank Ana Rita Coimbra Motta Castro (Universidade Federal de Mato Grosso do Sul–UFMS and Fiocruz Mato Grosso do Sul) and her students for support collecting samples and assisting with laboratory activities, as well as James R. Welch for technical and English language revisions.
References
- 1. Barros LEP. O processo histórico dos quilombos e o caso de Furnas de Dionísio Revista IDeAS. 2011; 5 (1): 274–291. https://dialnet.unirioja.es/descarga/articulo/4060648.pdf, acessed Mar 27, 2017.
- 2.
Brazil. Secretaria de Políticas de Promoção da Igualdade Racial. Secretaria de Políticas para Comunidades Tradicionais. Guia de Políticas Públicas das Comunidades Quilombolas. Programa Quilombola, Brasil, 2013. http://www.seppir.gov.br/portal-antigo/arquivos-pdf/guia-pbq, acessed Dec 15, 2016.
- 3. Tarleton RL. Chagas disease: a solvable problem, ignored. Trends in Molecular Medicine. 2016; october 22(10): 835–838. http://dx.doi.org/10.1016/j.molmed.2016.07.008 pmid:27523778
- 4. Almeida PS, Ceretti Júnior W, Obara MT, Santos HR, Barata JMS, Faccenda O. Levantamento da fauna de Triatominae (Hemiptera: Reduviidae) em ambiente domiciliar e infecção natural por Trypanosomatidae no Estado de Mato Grosso do Sul. Revista da Sociedade Brasileira de Medicina Tropical. 2008; jul-ago 41(4):374–380.
- 5. Forattini OP. Biogeografia, Origem e Distribuição: Domiciliação de Triatomíneos no Brasil. Revista de Saúde Pública. 1980; 14:265–299. pmid:7015472
- 6. Silveira AC, Feitosa VR, Borges R. Distribuição de triatomíneos capturados no ambiente domiciliar, no período de 1975/83, Brasil. Revista Brasileira de Malariologia de Doenças Tropicais. 1984; 36:15–312.
- 7. Cominetti MC, Andreotti R, Oshiro ET, Dorval MEMC. Epidemiological factors related to the transmission risk of Trypanosoma cruzi in a Quilombola community, State of Mato Grosso do Sul, Brazil. Revista da Sociedade Brasileira de Medicina Tropical. 2011; 44(5):576–581. pmid:22031072
- 8. Souza AI, Oliveira TMFS, Machado RZ, Camacho AA. Seroprevalence of infection by Trypanosoma cruzi in dogs in a rural area of Mato Grosso do Sul, Brazil; Pesquisa Veterinária Brasileira. 2009; 29(2):150–152.
- 9. Borges-Pereira J, Zauza PL, Galhardo MC, Nogueira JS Pereira GROL, Cunha RV. Doença de Chagas na população urbana do distrito Sanitário de Rio Verde, Mato Grosso do Sul, Brasil. Revista da Sociedade Brasileira de Medicina Tropical. 2001; set-out 34(5): 459–466. pmid:11600912
- 10. Pompilio MA, Dorval MEMC, Cunha RV, Britto C, Borges-Pereira J. Aspectos epidemiológicos, clínicos e parasitológicos da doença de Chagas em Mato Grosso do Sul. Revista da Sociedade Brasileira de Medicina Tropical. 2005: nov-dez; 38(6):473–478. http://dx.doi.org/10.1590/S0037-86822005000600005 pmid:16410921
- 11. Nunes VL, Dorval ME, Oshiro ET, Noguchi RC, Arão LB, Hans Filho G, et al. Estudo epidemiológico sobre Leishmaniose Tegumentar (LT) no município de Corguinho, Mato Grosso do Sul—estudos na população humana. Revista da Sociedade Brasileira de Medicina Tropical. 1995; 28: 185–93.
- 12. Sturm NR, Degrave W, Morel C, Simpson L. Sensitive detection and schizodeme classification of Trypanosoma cruzi by amplification of kinetoplast minicircle DNA sequences use diagnosis of Chagas disease. Molecular Biochemistry Parasitology. 1989; 33:205–214.
- 13. Ochs DE, Hnilica VS, Moser DR, Smith JH, Kirchhoff LV. Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene. 1996; 54: 526–529. pmid:8644910
- 14. Marcon GEB, Albuquerque DM, Batista AM, Andrade PD, Almeida EA, Guariento ME, et al. Trypanosoma cruzi: parasite persistence in tissues in chronic chagasic Brazilian patients. Memórias do Instituto Oswaldo Cruz. 2011; 106 (1): 85–91. pmid:21340361
- 15. Dias J. C. P. Elimination of Chagas disease transmission: perspectives. Memórias do Instituto Oswaldo Cruz. 2009; 104: 41–45. pmid:19753456
- 16. Coura JR. Chagas disease: control, elimination and eradication. Is it possible? Memórias do Instituto Oswaldo Cruz. 2013; 108 (8): 962–967. pmid:24402148
- 17. Abad-Franch F, Diotaiuti L, Gurgel-Gonçalves R, Gürtler RE. Certifying the interruption of Chagas disease transmission by native vectors: cui bono? Memórias do Instituto Oswaldo Cruz. 2013; 108: 251–254 pmid:23579810
- 18. Coura JR, Abad-Franch F, Aguilera X, Dias JCP, Junqueira ACV, Lima JF et al. The iniciative for the control of Chagas disease in the Americas and in non-endemic countries. Revista da Sociedade Brasileira de Medicina Tropical. 2009; 42 (Suppl. II): 106–110.
- 19. Ferreira ILM, Silva TPT. Eliminação da transmissão da doença de Chagas pelo Triatoma infestans no Brasil: um fato histórico. Revista da Sociedade Brasileira de Medicina Tropical. 2006; 39 (5): 507–509.
- 20. Roque AL, Xavier SC, Rocha MG, Duarte AC, D'Andrea PS, Jansen AM. Trypanosoma cruzi transmission cycle among wild and domestic mammals in three areas of orally transmitted Chagas disease outbreaks. American Journal of Tropical Medicine and Hygiene. 2008; Nov 79(5):742–9. pmid:18981516
- 21. Umezawa ES, Souza AI, Pinedo-Cancino V, Marcondes M, Marcili A, Camargo LMA, et al. TESA-blot for the diagnosis of Chagas disease in dogs from co-endemic regions for Trypanosoma cruzi, Trypanosoma evansi and Leishmania chagasi. Acta Tropica. 2009; Jul 111 (1):15–20. http://www.sciencedirect.com/science/article/pii/S0001706X09000084) accessed feb 15, 2017. pmid:19426657
- 22. Dias JCP, Ramos AN Jr, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR et al. II Consenso Brasileiro em Doença de Chagas. Epidemiologia e Serviços de Saúde. 2015; 25 (esp): 86. http://scielo.iec.pa.gov.br/scielo.php?script=sci_arttext&pid=S1679-49742016000500007&lng=pt accessed mar 25, 2017.
- 23. Marcon GEB, Andrade PD, Albuquerque DM, Wanderley JS, Almeida EA, Guariento ME, et al. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagnostic Microbiology and Infectious Disease. 2001; 43: 39–43.
- 24. Americano do Brasil PEA Castro R, Castro L. Commercial enzyme-linked immunosorbent assay versus polymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysis. Mem Inst Oswaldo Cruz, RJ. 2016; 111(1): 1–19.
- 25. Batista AM, Aguiar C, Almeida EA, Guariento ME, Wanderley JS, Costa SCB. Evidence of Chagas disease in soronegative Brazilian patients with megaesophagus. International Journal of Infectious Diseases.2010; 14: 974–977.
- 26. Malan AK, Avelar E, Litwin SE, Hill HR, Litwin CM. Serological diagnosis of Trypanosoma cruzi: evaluation of three enzyme immunoassays and an indirect immunofluorescent assay. Journal of Medical Microbiology. 2006; 55(Pt2): 171–8.
- 27. Abras A, Gállego M, Llovet T, Tebar S, Herrero M, Berenguer P, et al. Serological diagnosis of chronic Chagas disease: Is it time for a change? Journal of Clinical Microbiology. 2016; 54(6): 1566–72. pmid:27053668
- 28. Coura JR, Borges-Pereira J. Chagas disease: What is known and what should be improved: a systemic review Revista da Sociedade Brasileira de Medicina Tropical. 2012; 45(3): 286–296. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822012000300002&lng=en. http://dx.doi.org/10.1590/S0037-86822012000300002. pmid:22760123
- 29. Pompilio MA, Dorval MEMC, Cunha RV, Britto C, Borges-Pereira J. Análise clínica-epidemiológica de 200 casos de Doença de Chagas atendidos no HU-UFMS de 1986–1996. Revista da Sociedade Brasileira de Medicina Tropical, Uberaba. 1998; 31:214.
- 30. Silveira AC, Vinhaes MC. Elimination of Vector-borne Transmission of Chagas Disease. Mem Inst Oswaldo Cruz, RJ. 1999; 94 Suppl I: 405–411.
- 31. Borges-Pereira J, Zauza PL, Galhardo MC, Nogueira JS, Pereira GROL, Cunha RV. Chagas' disease on urban population of the sanitarian district of Rio Verde, Mato Grosso do Sul State, Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 2001; 34(5): 459–466. http://dx.doi.org/10.1590/S0037-86822001000500009 pmid:11600912
- 32. Cominetti MC, Almeida RFC, Goncalves GMA, Andreotti R. Monitoring Trypanosoma cruzi infection in triatomines using PCR in Mato Grosso do Sul, Brazil. Revista da Sociedade Brasileira de Medicina Tropical. 2013; 46 (3): 277–280. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S003786822013000300277&lng=en. http://dx.doi.org/10.1590/0037-8682-0024-2013. pmid:23856864
- 33. Monteón V, Solis-Oviedo R, Lopez R, Hernández O, Tellez CA. Low seroprevalence of Trypanosoma cruzi infection and chronic chagasic cardiomyopathy in a region with abundance of triatomine vectors in Yucatan Peninsula of Mexico. Annals of Parasitology. 2015; 61(4): 263–267. pmid:26878624
- 34. Kramm MD III, Gutierrez MR, Luepke TD, Soria C, Lopez RR, Cooper SM, et al. Trypanosoma cruzi in free-ranging mammalian populations in south Texas. Journal of Wildlife Diseases. 2017; 53(4) [Epub ahead of print]. pmid:28513328
- 35. Mackey TK, Liang BA. Threats from emerging and re-emerging neglected tropical diseases (NTDs). Infection Ecology and Epidemiology. 2012; 2: 18667 - http://dx.doi.org/10.3402/iee.v2i0.18667.